FDA Disclaimer

A study conducted by the U.S. Congress in 1969 revealed that 37 of 49 top officials who left the FDA moved into high profile corporate positions with the large companies they were regulating. A General Accounting Office (GAO) study of the FDA in 1975 revealed that 150 FDA officials owned stock in the companies they were supposed to regulate. These arrangements could explain why the FDA removed Renee Dufault from the majority of her field work after she discovered mercury in high fructose corn syrup! The FDA said we have to use this disclaimer regarding HCG. HCG has not been demonstrated to be effective adjunctive therapy in the treatment of obesity. There is no substantial evidence that it increases weight loss beyond that resulting from caloric restriction, that it causes a more attractive or “normal” distribution of fat, or that it decreases the hunger and discomfort associated with calorie-restricted diets.

However, hundreds of our clients and hundreds of thousands of die-hard HCG participants around the globe respectfully disagree. It is odd, obesity is the largest single preventable health epidemic facing America; it has been clearly linked to diabetes, cancer, and coronary disease; to us, treating obesity, and reducing the occurrence of the chronic illnesses that are directly linked to it, seems to make more sense than treating the chronic illness after the fact. At Success Weightloss Systems we believe that an ounce of prevention is worth a pound of cure. We often question the viability and safety of the countless diet drugs that were fast tracked by the FDA; years later, drugs like Phen-Phen were clearly linked to extensive heart damage, others were clearly linked to kidney, liver and heart damage. Current information in the healthcare database from the providence of Ontario indicate that patients that take Orlistat are at a greater risk for liver and kidney damage. Orlistat is the active ingredient in the diet drugs Xenical and Alli.

Here is another interesting event of FDA history that all parents should read. A recent report by the Edmond’s Institute includes the names of numerous individuals who move in and out of key positions with the FDA and the very Companies they are supposed to regulate. Here is but one example; in order for the FDA to determine if Monsanto’s growth hormones were safe or not, Monsanto was required to submit a scientific report on that topic. Margaret Miller, one of Monsanto’s researchers, put the report together. Shortly before the report submission, Miller left Monsanto and was hired by the FDA. Her first job for the FDA was to determine whether or not to approve the report she wrote for Monsanto. In short, Monsanto approved its own report. Assisting Miller was another former Monsanto researcher, Susan Sechen. Deciding whether or not rBGH-derived milk should be labeled, fell under the jurisdiction of another FDA official. Michael Taylor, who previously worked as a lawyer for Monsanto, served as a top executive, lawyer and lobbyist for Monsanto. In an earlier stint with the FDA Michael helped write the rules to allow (Bovine Growth Hormone) into the American food system and our children’s milk. The worst part, this prevalent conflict of interest has been going on for decades!

Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Not readable? Change text.

Start typing and press Enter to search